🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s BMY Holdings & Trades

First Buy
Q3 2018
Duration Held
13 Quarters
Largest Add
Q3 2018
+148,610 Shares
Current Position
34,008 Shares
$2.12 M Value

Lee Ainslie's BMY Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 34,008 shares of Bristol-Myers Squibb Company (BMY) worth $2.12 M, representing 0.02% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 13 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in BMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2019, adding 138,060 shares. Largest reduction occurred in Q4 2018, reducing 148,610 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's Bristol-Myers Squibb Company (BMY) Holding Value Over Time

Track share changes against reported price movement

Quarterly Bristol-Myers Squibb Company (BMY) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +34,008 New Buy 34,008 $62.40
Q2 2021 -40,241 Sold Out 0 $0.00
Q1 2021 +17,692 Add 78.46% 40,241 $63.12
Q4 2020 +15,382 Add 214.62% 22,549 $62.04
Q3 2020 -58,206 Reduce 89.04% 7,167 $60.28
Q2 2020 -3,580 Reduce 5.19% 65,373 $58.80
Q1 2020 -46,300 Reduce 40.17% 68,953 $55.73
Q4 2019 -9,259 Reduce 7.44% 115,253 $64.19
Q3 2019 +3,512 Add 2.90% 124,512 $50.71
Q2 2019 -17,060 Reduce 12.36% 121,000 $45.35
Q1 2019 +138,060 New Buy 138,060 $47.71
Q4 2018 -148,610 Sold Out 0 $0.00
Q3 2018 +148,610 New Buy 148,610 $62.08

Lee Ainslie's Bristol-Myers Squibb Company Investment FAQs

Lee Ainslie first purchased Bristol-Myers Squibb Company (BMY) in Q3 2018, acquiring 148,610 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held Bristol-Myers Squibb Company (BMY) for 13 quarters since Q3 2018.

Lee Ainslie's largest addition to Bristol-Myers Squibb Company (BMY) was in Q3 2018, adding 148,610 shares worth $9.23 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 34,008 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $2.12 M.

As of the Q3 2026 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.02% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in Bristol-Myers Squibb Company (BMY) was 148,610 shares, as reported at the end of Q3 2018.